Author:
Dal Molin Marco,Kim Haeryoung,Blackford Amanda,Sharma Rajni,Goggins Michael
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference40 articles.
1. Pharmacology, physiology, and mechanisms of incretin hormone action.;Campbell;Cell Metab,2013
2. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.;Elashoff;Gastroenterology,2011
3. Deutschen rzteschaft: NAus der UAW-Datenbanki Pankreaskarzinome im Zusammenhang mit Exenatid (Byetta AE).;Dtsch Arztebl International,2011
4. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.;Butler;Diabetes,2013
5. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe Diabetes Care.;Butler,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献